| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.MAT.0000085672.42122.49 |
| P953 | full work available at URL | http://journals.lww.com/00003086-200307000-00032 |
| P698 | PubMed publication ID | 14524557 |
| P50 | author | Matthias Loebe | Q114312358 |
| George P. Noon | Q63983726 | ||
| P2093 | author name string | Larry O. Thompson | |
| P2860 | cites work | Journal of Immunology | Q3521441 |
| Transactions - American Society for Artificial Internal Organs | Q27713636 | ||
| The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes | Q28572498 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Preventing, minimizing, and managing postoperative bleeding | Q78214047 | ||
| Infection during circulatory support with ventricular assist devices | Q78214052 | ||
| Fungal left ventricular assist device endocarditis | Q32110630 | ||
| CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism | Q33178865 | ||
| Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices | Q33332564 | ||
| An overview of tumor necrosis factor alpha and the failing human heart. | Q33652558 | ||
| Ventricular assistance for recovery of cardiac failure | Q33652582 | ||
| Concerning thromboembolism associated with left ventricular assist devices | Q33704098 | ||
| The role of dendritic cells in the induction and regulation of immunity to microbial infection. | Q33711401 | ||
| The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy | Q33784067 | ||
| Immunobiology of left ventricular assist devices | Q33997883 | ||
| The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure | Q34027484 | ||
| Left ventricular assist device implantation: short and long-term surgical complications | Q34052110 | ||
| Infectious complications associated with ventricular assist systems | Q34100726 | ||
| Fungal infections in ventricular assist devices | Q34100732 | ||
| Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers | Q34100748 | ||
| Long-term use of a left ventricular assist device for end-stage heart failure. | Q34109624 | ||
| Neuropathology associated with ventricular assist devices: an autopsy series of 33 patients | Q34213860 | ||
| Infection with clinical ventricular assist devices: clinical therapy | Q34262579 | ||
| Left ventricular assist device infections: three case reports and a review of the literature | Q34507829 | ||
| Nosocomial cardiac infections | Q34532424 | ||
| World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic | Q34882491 | ||
| Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy--first results of the Halle Assist Induced Recovery Study (HAIR). | Q38325425 | ||
| Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices | Q40744716 | ||
| Evaluation of regional differences in right ventricular systolic function by acoustic quantification echocardiography and cine magnetic resonance imaging | Q40845809 | ||
| Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. | Q41307109 | ||
| Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response | Q41307127 | ||
| Cerebral and systemic embolization during left ventricular support with the Novacor N100 device | Q42053948 | ||
| Pseudointima in inflow conduits of left ventricular assist devices | Q42477157 | ||
| Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg15]aprotinin | Q42650758 | ||
| Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). | Q43586296 | ||
| B-type natriuretic peptide predicts sudden death in patients with chronic heart failure | Q43703424 | ||
| Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation | Q43886864 | ||
| Platelet glycoprotein IIb/IIIa inhibitor attenuates complement activation during in vitro ventricular assist circulation | Q43983554 | ||
| Transcranial detection of microembolic signals in patients with a novel nonpulsatile implantable LVAD. | Q44047860 | ||
| Protection of platelet glycoprotein IIb/IIIa receptor complex preserves platelet function during in vitro ventricular assisted circulation. | Q44324623 | ||
| Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide alpha-MSH. | Q47966638 | ||
| Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone | Q48099706 | ||
| Brain-IL-1beta induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system | Q48312063 | ||
| Vesnarinone and amrinone reduce the systemic inflammatory response syndrome | Q50127898 | ||
| Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. | Q50688653 | ||
| Factors influencing HLA sensitization in implantable LVAD recipients. | Q50926797 | ||
| Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. | Q52964272 | ||
| Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. | Q52979333 | ||
| Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device. | Q54213795 | ||
| Prostaglandin E1 and dibutyryl cyclic AMP enhance platelet resistance to deformation | Q54273800 | ||
| Platelet protective effect of TAK-029, a novel glycoprotein IIb/IIIa antagonist: an in vitro study. | Q54288875 | ||
| Development of an infection-resistant LVAD driveline: a novel approach to the prevention of device-related infections | Q57756343 | ||
| Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure | Q58071911 | ||
| Combined anti-coagulation protocol for the MicroMed DeBakey VAD: a proposal | Q63984828 | ||
| Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery | Q63984849 | ||
| Immunologic effects of implantation of left ventricular assist devices. | Q64990540 | ||
| Molecular, microscopic, microstructural and mechanical methods of analyzing pseudoneointimal linings within partial artificial hearts in man and the calf | Q67375319 | ||
| Systemic complement activation produces hemodynamic changes characteristic of sepsis | Q68265417 | ||
| Implantable LVAD infections: implications for permanent use of the device | Q70900247 | ||
| Thromboembolism and bleeding: clinical strategies | Q70900261 | ||
| Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation | Q70928492 | ||
| Hemostatic profiles of HeartMate ventricular assist device recipients | Q70931143 | ||
| Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor | Q71684060 | ||
| Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure | Q71807853 | ||
| Infectious complications in left ventricular assist device recipients | Q71972427 | ||
| Weekly variation of acute myocardial infarction. Increased Monday risk in the working population | Q72047977 | ||
| Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation | Q73120075 | ||
| Apoptosis in the failing human heart | Q73215232 | ||
| Measurement of hemostatic indexes in conjunction with transcranial doppler sonography in patients with ventricular assist devices | Q73230313 | ||
| A novel method to reduce device-related infections in patients supported with the HeartMate device | Q73235784 | ||
| Can infections be imaged in implanted devices? | Q73280198 | ||
| Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels | Q73283404 | ||
| Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface | Q73669698 | ||
| Inflammation and thrombosis: the clot thickens | Q73702701 | ||
| Long-term follow-up of aprotinin-specific immunoglobulin G antibodies after cardiac operations | Q73807572 | ||
| Alternative splicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium | Q73876791 | ||
| Clinical impact of infections in left ventricular assist device recipients: the importance of site and organism | Q73983758 | ||
| Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival | Q74014727 | ||
| Modulation of the tissue reaction to biomaterials. II. The function of T cells in the inflammatory reaction to crosslinked collagen implanted in T-cell-deficient rats | Q74190743 | ||
| Nosocomial bloodstream infections in patients with implantable left ventricular assist devices | Q74534861 | ||
| Neurohormonal changes after implantation of a left ventricular assist system | Q74819779 | ||
| Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression | Q77370029 | ||
| Vitamin K reduces bleeding in left ventricular assist device recipients | Q77396017 | ||
| Complement activation in patients undergoing mechanical circulatory support | Q77519817 | ||
| Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps | Q77730165 | ||
| Inflammatory response to cardiopulmonary bypass | Q77737953 | ||
| Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump | Q77739308 | ||
| Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem | Q77779651 | ||
| Inflammatory mediators in heart failure: homogeneity through heterogeneity | Q77845562 | ||
| Surface texturing and coating of biomaterial implants: effects on tissue integration and fibrosis | Q78121040 | ||
| The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure | Q78155336 | ||
| Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response | Q78199146 | ||
| Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device | Q78201101 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomedical engineering | Q327092 |
| bioengineering | Q580689 | ||
| biophysics | Q7100 | ||
| P304 | page(s) | 518-526 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | ASAIO Journal | Q15751141 |
| P1476 | title | What price support? Ventricular assist device induced systemic response | |
| What Price Support? Ventricular Assist Device Induced Systemic Response | |||
| P478 | volume | 49 |
| Q37727496 | A numerical study of blood flow using mixture theory |
| Q33626799 | A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index. |
| Q92066616 | Antithrombotic therapy for patients with total artificial hearts |
| Q38363600 | Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart-transplantation patient |
| Q38913801 | Comparison of Blood Viscoelasticity in Pediatric and Adult Cardiac Patients |
| Q35140316 | Design of a pulsatile flow facility to evaluate thrombogenic potential of implantable cardiac devices |
| Q41379944 | Percutaneous dilatational tracheostomy following total artificial heart implantation |
| Q37826020 | Pharmacotherapy for mechanical circulatory support: a comprehensive review |
| Q41852891 | Surface modification of a titanium alloy with a phospholipid polymer prepared by a plasma-induced grafting technique to improve surface thromboresistance. |
| Q34149690 | The use of computational fluid dynamics in the development of ventricular assist devices |
Search more.